Chenling Capital
Overview
Chenling Capital is an international investment management company that focuses on private equity investments in the healthcare, high-end manufacturing, and TMT sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hangzhou DAC Biotechnology Co., Ltd. | May 2021 | Series C | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Chenling Capital based?
Chenling Capital is headquartered in Hong Kong, Hong Kong.
When was Chenling Capital founded?
Chenling Capital was founded in 2016.
How many portfolio companies does Chenling Capital have?
Chenling Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Chenling Capital's portfolio?
Portfolio companies visible on Caplight include Hangzhou DAC Biotechnology Co., Ltd..
What was Chenling Capital's most recent investment shown here?
Chenling Capital's most recent investment in this portfolio sample was in Hangzhou DAC Biotechnology Co., Ltd. in 2021.
What sectors does Chenling Capital focus on?
Chenling Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Chenling Capital focus on?
Chenling Capital typically invests at the Mid stage.